SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-002488
Filing Date
2024-01-04
Accepted
2024-01-04 16:46:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d16394ds3.htm S-3 445736
2 EX-5.1 d16394dex51.htm EX-5.1 8542
3 EX-23.1 d16394dex231.htm EX-23.1 2411
4 EX-FILING FEES d16394dexfilingfees.htm EX-FILING FEES 14024
5 GRAPHIC g16394g0103020951283.jpg GRAPHIC 4100
6 GRAPHIC g16394g17k12.jpg GRAPHIC 69855
  Complete submission text file 0001193125-24-002488.txt   573885
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276374 | Film No.: 24512795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)